EA201990341A1 - Замещенные диазагетеробициклические соединения и их применение - Google Patents
Замещенные диазагетеробициклические соединения и их применениеInfo
- Publication number
- EA201990341A1 EA201990341A1 EA201990341A EA201990341A EA201990341A1 EA 201990341 A1 EA201990341 A1 EA 201990341A1 EA 201990341 A EA201990341 A EA 201990341A EA 201990341 A EA201990341 A EA 201990341A EA 201990341 A1 EA201990341 A1 EA 201990341A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- substituted
- diazaheterobicyclic
- application
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Настоящее изобретение касается новых (имидазо[1,2-a]пиридин-3-ил)метилзамещенных диазагетеробициклических соединений, способов их получения, их применения отдельно или в комбинациях для лечения и/или предупреждения заболеваний, а также их применения для изготовления лекарственных средств для лечения и/или предупреждения заболеваний, в частности для лечения и/или предупреждения нарушений дыхания, включая нарушения дыхания во время сна, такие как синдром обструктивного и центрального апноэ сна и храпа. Далее настоящее изобретение касается способа обнаружения соединения с блокирующими TASK-1 и/или TASK-3 свойствами.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16203964 | 2016-12-14 | ||
PCT/EP2017/067273 WO2018015196A1 (de) | 2016-07-20 | 2017-07-10 | Substituierte diazaheterobicyclische verbindungen und ihre verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201990341A1 true EA201990341A1 (ru) | 2019-08-30 |
EA039175B1 EA039175B1 (ru) | 2021-12-14 |
Family
ID=57569970
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201990341A EA039175B1 (ru) | 2016-12-14 | 2017-07-10 | Замещенные диазагетеробициклические соединения, способ их получения и их применение |
EA202192558A EA202192558A1 (ru) | 2016-12-14 | 2017-07-10 | Замещенные диазагетеробициклические соединения и их применение |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202192558A EA202192558A1 (ru) | 2016-12-14 | 2017-07-10 | Замещенные диазагетеробициклические соединения и их применение |
Country Status (1)
Country | Link |
---|---|
EA (2) | EA039175B1 (ru) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10220570A1 (de) * | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
EP2300470A2 (en) * | 2008-05-19 | 2011-03-30 | Sepracor Inc. | Imidazo[1,2-a]pyridine compounds as gaba-a receptor modulators |
EP2691392A1 (en) * | 2011-03-31 | 2014-02-05 | EMBLEM Technology Transfer GmbH | Imidazo [1,2-a]pyridine compounds for use in therapy |
-
2017
- 2017-07-10 EA EA201990341A patent/EA039175B1/ru unknown
- 2017-07-10 EA EA202192558A patent/EA202192558A1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
EA202192558A1 (ru) | 2021-12-07 |
EA039175B1 (ru) | 2021-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201891374A1 (ru) | Замещенные 2-фенил-3-(пиперазинметил)имидазопиридины и их применение | |
EA202090043A1 (ru) | Диазабициклические замещенные имидазопиримидины и их применение | |
PH12019500131A1 (en) | Substituted diazahetero-bicyclic compounds and their use | |
EA201591290A2 (ru) | Креноланиб для лечения пролиферативных расстройств, связанных с мутацией flt3 | |
PH12019501408A1 (en) | Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapy | |
PH12019501458A1 (en) | Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapy | |
EA201600318A1 (ru) | Циклические тиеноурацилкарбоксамиды и их применение | |
EA201691656A2 (ru) | Терапевтические способы с применением норибогаина и родственных соединений | |
WO2016025671A3 (en) | Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist | |
EA202191480A1 (ru) | Способ получения фармацевтических лекарственных форм, содержащих ингибиторы task-1- и task-3-каналов, и их применение для терапии нарушений дыхания | |
EA201990341A1 (ru) | Замещенные диазагетеробициклические соединения и их применение | |
EA201991538A1 (ru) | Фармацевтические лекарственные формы, содержащие ингибиторы каналов task-1 и task-3, и их применение для лечения нарушений дыхания | |
EA201991540A1 (ru) | Фармацевтические лекарственные формы, содержащие ингибиторы каналов task-1 и task-3 и их применение для лечения нарушений дыхания |